Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
US Stock MarketDetailed Quotes
ABVX Abivax S.A.
- 7.190
- +0.280+4.05%
Close May 2 16:00 ET
- 7.190
- 0.0000.00%
Post 16:00 ET
455.73MMarket Cap-2.27P/E (TTM)
7.450High7.075Low138.29KVolume7.290Open6.910Pre Close1.01MTurnover0.43%Turnover RatioLossP/E (Static)63.38MShares15.06052wk High9.94P/B230.13MFloat Cap4.77052wk Low--Dividend TTM32.01MShs Float17.020Historical High--Div YieldTTM5.43%Amplitude4.770Historical Low7.267Avg Price1Lot Size
About Abivax S.A. Company
Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.
Company Profile
SymbolABVX
Company NameAbivax S.A.
Issue Price11.60
Founded2013
CEOMr. Marc de Garidel
MarketNASDAQ
Employees69
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
Address7-11 Boulevard Haussmann
CityParis
ProvinceIle-de-France
CountryFrance
Zip Code75009
Phone33-1-53-83-09-63
Websitehttp://www.abivax.com
Company Executives
- Name
- Position
- Salary
- Marc de Garidel
- Chief Executive Officer and Chairman of the Board
- --
- Ida Hatoum
- Chief People Officer
- --
- Sheldon Sloan
- Chief Medical Officer
- --
- Pierre Courteille
- Chief Business Officer
- --
- Michael Ferguson
- Chief Commercial Officer
- --
- Didier Scherrer
- Chief Scientific Officer
- --
- Didier Blondel
- Chief Financial Officer and Secretary of the Board
- --
- Dr. Philippe Pouletty
- Director
- --
- Corinna zur Bonsen-Thomas
- Independent Director
- --
- Camilla Soenderby
- Independent Director
- --
- Troy A. Ignelzi
- Independent Director
- --
- Kinam Hong
- Independent Director
- --
- Dr. June Lee, M.D.
- Independent Director
- --
- Dr. Carol L. Brosgart, M.D.
- Independent Director
- --
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. Do you think Buffett was scooping up stocks during the recent dip? 2. In the face of market changes, do you prefer to stick
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call